Ching Chen
Impact in
- Immunology top 2%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Nephrology top 2%
- Parathyroid Disorders and Treatments
Papers in
- Immunology 15
- T-cell and B-cell Immunology 10
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 5
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Eline T. Luning Prak (3 shared papers)MARTIN G. WEIGERT (5 shared papers)Zoltán Á. Nagy (2 shared papers)Martin Weigert (1 shared paper)Marko Z. Radic (3 shared papers)Dennis Huszar (1 shared paper)Richard R. Hardy (1 shared paper)Sally Ann Camper (1 shared paper)
- Journals
- The Journal of Immunology (8 papers)Immunity (2 papers)Nature (1 paper)Schizophrenia Bulletin (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Ching Chen
32 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 88
- Immunology 982
- Nephrology 322
- Radiology, Nuclear Medicine and Imaging 402
- Rheumatology 206
- Hematology 110
Countries citing papers authored by Ching Chen
This map shows the geographic impact of Ching Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Chen more than expected).
Fields of papers citing papers by Ching Chen
This network shows the impact of papers produced by Ching Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Chen. The network helps show where Ching Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 332 | |
| 2 | 1995 | 264 | |
| 3 | 1995 | 252 | |
| 4 | 1997 | 189 | |
| 5 | Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. | 2003 | 155 |
| 6 | 2008 | 127 | |
| 7 | 2001 | 110 | |
| 8 | 2012 | 74 | |
| 9 | 2020 | 46 | |
| 10 | 2012 | 42 | |
| 11 | 2012 | 42 | |
| 12 | 2015 | 38 | |
| 13 | 2013 | 33 | |
| 14 | 2012 | 32 | |
| 15 | 2006 | 31 | |
| 16 | 2013 | 29 | |
| 17 | 2019 | 27 | |
| 18 | Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment. | 2019 | 26 |
| 19 | 2015 | 24 | |
| 20 | 2008 | 22 |
About Ching Chen
Ching Chen is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Hematology, Molecular Biology and Rheumatology, having authored 32 papers that have together received 2.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (5 papers), Systemic Lupus Erythematosus Research (4 papers), Fibroblast Growth Factor Research (3 papers), CRISPR and Genetic Engineering (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (982 citations), Nephrology (322 citations), Radiology, Nuclear Medicine and Imaging (402 citations), Rheumatology (206 citations) and Hematology (110 citations). Ching Chen has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Eline T. Luning Prak, MARTIN G. WEIGERT, Zoltán Á. Nagy, Martin Weigert, Marko Z. Radic, Dennis Huszar, Richard R. Hardy, Sally Ann Camper, J. H. Stevens and Yang Xu. Their work appears in journals such as The Journal of Immunology, Immunity, Nature, Schizophrenia Bulletin and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.